BDCA2 (Cyno) Cell Binding Assay, CHOK1/BDCA2-based (CAT#: ITS-1122-LX8)

CHOK1/BDCA2 (Cyno)

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. cyno BDCA2 Stable Cell Line, CHO-K1 is constructed to constitutively expressing cyno BDCA2. Which can be used in binding assays and functional assay.

CHOK1

Cancer

Oncology

In Vitro Cell Binding Assay

Useful for validating the binding affinity of BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) in a cellular context.

Cell-based binding assay is one of most commonly used assays for drug discovery and screening. Creative Biolabs provides In Vitro BDCA2 (Cyno) Cell Binding Assay to validate the binding affinity of 4-1BB (Human) binding molecules (such as anti-4-8BB antibody, ADC) by cell-based ELISA or cell-based FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Cell-based Binding Assay; Cell-based ELSA Binding; Cell-based FACS Binding

Cell Binding Assay

Validating the binding affinity of BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.

Creative have developed the stable cell line CHO-K1/BDCA2 (Cyno), which is designed for validating the binding affinity of BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.